Literature DB >> 1635550

Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.

K A Jacobson1, G L Stiles, X D Ji.   

Abstract

The ligand recognition site of A2a-adenosine receptors in rabbit striatal membranes was probed using non-site-directed labeling reagents and specific affinity labels. Exposure of membranes to diethylpyrocarbonate at a concentration of 2.5 mM, followed by washing, was found to inhibit the binding of [3H]CGS 21680 and [3H]xanthine amine congener to A2a receptors, by 86 and 30%, respectively. Protection from diethylpyrocarbonate inactivation by an adenosine receptor agonist, 5'-N-ethylcarboxamidoadenosine, and an antagonist, theophylline, suggested the presence of two histidyl residues on the receptor, one associated with agonist binding and the other with antagonist binding. Binding of [3H]CGS 21680 or [3H]xanthine amine congener was partially restored after incubation with 250 mM hydroxylamine, further supporting histidine as the modification site. Preincubation with disulfide-reactive reagents, dithiothreitol or sodium dithionite, at greater than 5 mM inhibited radioligand binding, indicating the presence of essential disulfide bridges in A2a receptors, whereas the concentration of mercaptoethanol required to inhibit binding was greater than 50 mM. A number of isothiocyanate-bearing affinity labels derived from the A2a-selective agonist 2-[(2-aminoethylamino) carbonylethylphenylethylamino]-5'-N- ethylcarboxamidoadenosine (APEC) were synthesized and found to inhibit A2a receptor binding in rabbit and bovine striatal membranes. Binding to rabbit A1 receptors was not inhibited. Preincubation with the affinity label 4-isothiocyanatophenylaminothiocarbonyl-APEC (100 nM) diminished the Bmax for [3H]CGS 21680 binding by 71%, and the Kd was unaffected, suggesting a direct modification of the ligand binding site. Reversal of 4-isothiocyanatophenylaminothiocarbonyl-APEC inhibition of [3H]CGS 21680 binding with hydroxylamine suggested that the site of modification by the isothiocyanate is a cysteine residue. A bromoacetyl derivative of APEC was ineffective as an affinity label at submicromolar concentrations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1635550      PMCID: PMC3429947     

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  24 in total

1.  [(3)H]XAC (xanthine amine congener) is a radioligand for A(2)-adenosine receptors in rabbit striatum.

Authors:  X D Ji; G L Stiles; K A Jacobson
Journal:  Neurochem Int       Date:  1991       Impact factor: 3.921

2.  Modification of histidyl residues in proteins by diethylpyrocarbonate.

Authors:  E W Miles
Journal:  Methods Enzymol       Date:  1977       Impact factor: 1.600

3.  Chemical modification of adenosine A1 receptors. Implications for the interaction with R-PIA, DPCPX and amiloride.

Authors:  A Garritsen; A P Ijzerman; M W Beukers; W Soudijn
Journal:  Biochem Pharmacol       Date:  1990-08-15       Impact factor: 5.858

4.  Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: evidence for synergism and antagonism.

Authors:  O Nikodijević; R Sarges; J W Daly; K A Jacobson
Journal:  J Pharmacol Exp Ther       Date:  1991-10       Impact factor: 4.030

5.  Chemical modification of A1 adenosine receptors in rat brain membranes. Evidence for histidine in different domains of the ligand binding site.

Authors:  K N Klotz; M J Lohse; U Schwabe
Journal:  J Biol Chem       Date:  1988-11-25       Impact factor: 5.157

6.  Separation of solubilized A2 adenosine receptors of human platelets from non-receptor [3H]NECA binding sites by gel filtration.

Authors:  M J Lohse; B Elger; J Lindenborn-Fotinos; K N Klotz; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-01       Impact factor: 3.000

7.  A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase.

Authors:  I Hide; W L Padgett; K A Jacobson; J W Daly
Journal:  Mol Pharmacol       Date:  1992-02       Impact factor: 4.436

8.  High affinity acylating antagonists for the A1 adenosine receptor: identification of binding subunit.

Authors:  G L Stiles; K A Jacobson
Journal:  Mol Pharmacol       Date:  1988-12       Impact factor: 4.436

9.  Probing the adenosine receptor with adenosine and xanthine biotin conjugates.

Authors:  K A Jacobson; K L Kirk; W Padgett; J W Daly
Journal:  FEBS Lett       Date:  1985-05-06       Impact factor: 4.124

Review 10.  Adenosine A1 and A2 receptors: structure--function relationships.

Authors:  P J van Galen; G L Stiles; G Michaels; K A Jacobson
Journal:  Med Res Rev       Date:  1992-09       Impact factor: 12.944

View more
  20 in total

1.  Molecular modeling of adenosine receptors. I. The ligand binding site on the A1 receptor.

Authors:  A P IJzerman; P J Van Galen; K A Jacobson
Journal:  Drug Des Discov       Date:  1992

2.  2-[2-[4-[2-[2-[ 1,3-Dihydro- 1,1-bis (4-hydroxyphenyl)-3-oxo-5-isobenzofuranthioureidyl]ethylaminocarbonyl]ethyl]phenyl] ethylamino]-5'-N-ethylcarboxamidoadenosine (FITC-APEC): A Fluorescent Ligand For A2a-Adenosine Receptors.

Authors:  R Tyler McCabe; Phil Skolnick; Kenneth A Jacobson
Journal:  J Fluoresc       Date:  1992-12       Impact factor: 2.217

3.  Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition.

Authors:  Q Jiang; A M Van Rhee; J Kim; S Yehle; J Wess; K A Jacobson
Journal:  Mol Pharmacol       Date:  1996-09       Impact factor: 4.436

4.  Modelling the P2Y purinoceptor using rhodopsin as template.

Authors:  A M Van Rhee; B Fischer; P J Van Galen; K A Jacobson
Journal:  Drug Des Discov       Date:  1995-11

5.  Molecular modeling of adenosine receptors. The ligand binding site on the rat adenosine A2A receptor.

Authors:  A P IJzerman; E M van der Wenden; P J van Galen; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1994-06-15       Impact factor: 4.432

6.  8-(3-Isothiocyanatostyryl)caffeine Is a Selective, Irreversible Inhibitor of Striatal A(2)-Adenosine Receptors.

Authors:  Xiao-Duo Ji; Carola Gallo-Rodriguez; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  2004-10-05       Impact factor: 4.360

7.  Covalent binding of a selective agonist irreversibly activates guinea pig coronary artery A2 adenosine receptors.

Authors:  K Niiya; K A Jacobson; S K Silvia; R A Olsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

8.  Molecular Characterization of A(1) and A(2a) Adenosine Receptors.

Authors:  Kenneth A Jacobson; Philip J M van Galen; Xiao-Duo Ji; Vickram Ramkumar; Mark E Olah; Gary L Stiles
Journal:  Drug Dev Res       Date:  2004-10-05       Impact factor: 4.360

9.  Solubilized rabbit striatal A2a-adenosine receptors: stability and antagonist binding.

Authors:  X D Ji; K A Jacobson
Journal:  Arch Biochem Biophys       Date:  1993-09       Impact factor: 4.013

10.  Application of the functionalized congener approach to dendrimer-based signaling agents acting through A(2A) adenosine receptors.

Authors:  Yoonkyung Kim; Athena M Klutz; Béatrice Hechler; Zhan-Guo Gao; Christian Gachet; Kenneth A Jacobson
Journal:  Purinergic Signal       Date:  2008-07-04       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.